
    
      Patients will have a short-course (4-weeks) administration of a given compound in the
      timeframe between the diagnostic biopsy and the surgical resection. A pre-treatment tumor
      biopsy will be obtained, and blood samples will be collected before, during, and at the end
      of treatment.
    
  